TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 NOK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 270,062 | 239,613 | 277,477 |
Financial expenses | 336 | 132 | 145 |
Earnings before taxes | -15,916 | -13,035 | -1,004 |
EBITDA | -15,306 | -86,175 | 7,917 |
Total assets | 288,981 | 312,989 | 149,016 |
Current assets | 288,276 | 311,813 | 104,015 |
Current liabilities | 78,804 | 69,734 | 106,723 |
Equity capital | 210,177 | 243,144 | 42,193 |
- share capital | 153 | 164 | 148 |
Employees (average) | 129 | 93 | 40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 72.7% | 77.7% | 28.3% |
Turnover per employee | 2,094 | 2,576 | 6,937 |
Profit as a percentage of turnover | -5.9% | -5.4% | -0.4% |
Return on assets (ROA) | -5.4% | -4.1% | -0.6% |
Current ratio | 365.8% | 447.1% | 97.5% |
Return on equity (ROE) | -7.6% | -5.4% | -2.4% |
Change turnover | 47,005 | -67,899 | 1,018 |
Change turnover % | 21% | -22% | 0% |
Chg. No. of employees | 36 | 53 | 11 |
Chg. No. of employees % | 39% | 133% | 38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.